University of Gothenburg

Individuals with Down syndrome face significantly higher risks of stroke, with hemorrhagic stroke risk 5.14 times higher and ischemic stroke risk 4.41 times higher than the general population.

A clinical trial presented at the European Respiratory Society Congress 2024 suggests sulthiame, an epilepsy drug, reduces sleep apnea symptoms.